Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

MicroRNAs and their target gene networks in breast cancer.

O'Day E, Lal A.

Breast Cancer Res. 2010;12(2):201. doi: 10.1186/bcr2484. Epub 2010 Mar 19. Review.

2.

miRNA-34a is associated with docetaxel resistance in human breast cancer cells.

Kastl L, Brown I, Schofield AC.

Breast Cancer Res Treat. 2012 Jan;131(2):445-54. doi: 10.1007/s10549-011-1424-3. Epub 2011 Mar 12.

PMID:
21399894
3.

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A.

J Pathol. 2009 Oct;219(2):214-21. doi: 10.1002/path.2586.

PMID:
19593777
4.

MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.

Aydoğdu E, Katchy A, Tsouko E, Lin CY, Haldosén LA, Helguero L, Williams C.

Carcinogenesis. 2012 Aug;33(8):1502-11. doi: 10.1093/carcin/bgs161. Epub 2012 May 4.

PMID:
22562546
5.

MicroRNA gene expression deregulation in human breast cancer.

Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM.

Cancer Res. 2005 Aug 15;65(16):7065-70.

6.

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.

Tahiri A, Leivonen SK, Lüders T, Steinfeld I, Ragle Aure M, Geisler J, Mäkelä R, Nord S, Riis ML, Yakhini Z, Kleivi Sahlberg K, Børresen-Dale AL, Perälä M, Bukholm IR, Kristensen VN.

Carcinogenesis. 2014 Jan;35(1):76-85. doi: 10.1093/carcin/bgt333. Epub 2013 Oct 8.

PMID:
24104550
7.

Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.

Patel JB, Appaiah HN, Burnett RM, Bhat-Nakshatri P, Wang G, Mehta R, Badve S, Thomson MJ, Hammond S, Steeg P, Liu Y, Nakshatri H.

Oncogene. 2011 Mar 17;30(11):1290-301. doi: 10.1038/onc.2010.510. Epub 2010 Nov 8.

PMID:
21057539
8.

MicroRNA involvement in the pathogenesis and management of breast cancer.

Khoshnaw SM, Green AR, Powe DG, Ellis IO.

J Clin Pathol. 2009 May;62(5):422-8. doi: 10.1136/jcp.2008.060681. Review.

PMID:
19398594
9.

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.

Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T, Schneeweiss A, Sahin O, Wiemann S, Tschulena U.

Oncogene. 2012 Sep 13;31(37):4150-63. doi: 10.1038/onc.2011.571. Epub 2011 Dec 12.

PMID:
22158050
10.

MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.

Zhao L, Sun Y, Hou Y, Peng Q, Wang L, Luo H, Tang X, Zeng Z, Liu M.

Int J Biochem Cell Biol. 2012 Nov;44(11):2051-9. doi: 10.1016/j.biocel.2012.08.005. Epub 2012 Aug 13.

PMID:
22964023
11.

Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer.

Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, Recker RR, Xiao GG.

Breast Cancer Res Treat. 2011 May;127(1):69-80. doi: 10.1007/s10549-010-0972-2. Epub 2010 Jun 10.

PMID:
20535543
12.

Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.

Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H.

Breast Cancer Res Treat. 2011 Nov;130(1):331-9. doi: 10.1007/s10549-011-1672-2. Epub 2011 Jul 14.

PMID:
21755340
13.

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.

Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY.

Breast Cancer Res Treat. 2012 Aug;134(3):1081-93. doi: 10.1007/s10549-012-2034-4. Epub 2012 Apr 4.

PMID:
22476851
14.

Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.

Canturk KM, Ozdemir M, Can C, Öner S, Emre R, Aslan H, Cilingir O, Ciftci E, Celayir FM, Aldemir O, Özen M, Artan S.

Mol Biol Rep. 2014 Dec;41(12):8127-35. doi: 10.1007/s11033-014-3713-5. Epub 2014 Sep 5.

PMID:
25189652
15.

MicroRNA expression profiling of male breast cancer.

Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A.

Breast Cancer Res. 2009;11(4):R58. doi: 10.1186/bcr2348. Epub 2009 Aug 10.

16.

The role of microRNAs in breast cancer migration, invasion and metastasis.

Tang J, Ahmad A, Sarkar FH.

Int J Mol Sci. 2012 Oct 18;13(10):13414-37. doi: 10.3390/ijms131013414. Review.

17.

microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis.

Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y.

Cancer Res. 2009 Jul 15;69(14):5970-7. doi: 10.1158/0008-5472.CAN-09-0236. Epub 2009 Jun 30. Erratum in: Cancer Res. 2009 Aug 15;69(16):6758.

18.

miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.

Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, Liao DZ, Huang MY, Hou JH, Wu QL, Zeng MS, Huang WL, Zeng YX, Shao JY.

Cancer Res. 2011 May 15;71(10):3552-62. doi: 10.1158/0008-5472.CAN-10-2435. Epub 2011 Mar 28.

19.

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, Hannon GJ, Stebbing J.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15732-7. doi: 10.1073/pnas.0906947106. Epub 2009 Aug 24.

20.

Analysis of serum genome-wide microRNAs for breast cancer detection.

Wu Q, Wang C, Lu Z, Guo L, Ge Q.

Clin Chim Acta. 2012 Jul 11;413(13-14):1058-65. doi: 10.1016/j.cca.2012.02.016. Epub 2012 Feb 23.

PMID:
22387599

Supplemental Content

Support Center